Signet Healthcare Partners and Windham Capital Partners Lead Majority Recapitalization of PainTEQ

August 27, 2025

PainTEQ, a Tampa-based developer of minimally invasive sacroiliac (SI) joint implants, completed a majority growth recapitalization co-led by Signet Healthcare Partners and Windham Capital Partners with a new equity investment from MVolution Partners. The capital will fund clinical studies, next-generation product development and expansion of PainTEQ's U.S. commercial presence; transaction terms were not disclosed.

Buyers
Signet Healthcare Partners, Windham Capital Partners, MVolution Partners
Targets
PainTEQ
Industry
Medical Devices
Location
Florida, United States
Transaction Type
Recapitalization

Explore More

Build a buyer list for your deal

Find active buyers from recent acquisition patterns and move straight into outreach.